HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma

NCT02370160 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Refractory B-Lineage Leukemia
Relapsed B-Lineage Leukemia
Refractory B-Lineage Lymphoma
Relapsed B-Lineage Lymphoma

Interventions

BIOLOGICAL: DT2219ARL

Sponsor

Masonic Cancer Center, University of Minnesota